The p210 protein occurs was observed in more than 90% of CML patients and has been hypothesized to be the initial step in the pathogenesis of CML (Arana-Trejo et al., 2002). The gene discussed is EVPL; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.